The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.
Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL.
Green DM, et al. Among authors: whitton ja.
Pediatr Blood Cancer. 2014 Jan;61(1):53-67. doi: 10.1002/pbc.24679. Epub 2013 Aug 12.
Pediatr Blood Cancer. 2014.
PMID: 23940101
Free PMC article.